Cargando…
Combined Intravitreal Bevacizumab And Dexamethasone In Bilateral Lupus Retinopathy
This paper reports and discusses a case of bilateral lupus retinopathy with macular edema in a patient diagnosed with systemic lupus retinopathy and treated with combined intravitreal bevacizumab (0.025 mL/0.625 mg) and intravitreal dexamethasone (0.05 mL/0.2 mg). The patient was a 25-year-old femal...
Autores principales: | Shrestha, Ruchi, Kharel Sitaula, Ranju, Karki, Pratap, Joshi, Sagun Narayan, Rawal, Suniti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826195/ https://www.ncbi.nlm.nih.gov/pubmed/31802954 http://dx.doi.org/10.2147/IMCRJ.S220499 |
Ejemplares similares
-
Evaluation of effect of bevacizumab on central subfield macular thickness in the injected and contralateral (untreated) eye of patients with bilateral diabetic macular oedema
por: Khatri, Anadi, et al.
Publicado: (2017) -
Outcome of intravitreal bevacizumab injection without pre and postoperative antibiotics
por: Shrestha, Ruchi, et al.
Publicado: (2020) -
Role of lupus retinopathy in systemic lupus erythematosus
por: Kharel (Sitaula), Ranju, et al.
Publicado: (2016) -
Panophthalmitis secondary to retained intraocular foreign body amidst a national lockdown during the COVID-19 pandemic: A case series and review of literature
por: Pandit, Kamal, et al.
Publicado: (2022) -
Youngest reported Seasonal Hyperacute Panuveitis case
por: Kharel (Sitaula), Ranju, et al.
Publicado: (2019)